Gilead Sciences Inc
(XTER:GIS)
€
114.1
-0.76 (-0.66%)
Market Cap: 143.26 Bil
Enterprise Value: 155.94 Bil
PE Ratio: 17.90
PB Ratio: 6.94
GF Score: 82/100 Gilead Sciences Inc at Cowen Health Care Conference (Virtual) Transcript
Mar 09, 2022 / 03:30PM GMT
Release Date Price:
€53.82
(-2.39%)
Tyler Martin Van Buren
Cowen and Company, LLC, Research Division - Analyst
Good morning, everyone. Welcome to the third day of Cowen's 42nd Annual Healthcare Conference. My name is Tyler Van Buren. I'm a senior biotech analyst here at Cowen. For this next session, we have a fireside chat with Gilead. It's my pleasure to introduce Andy Dickinson, Gilead's Chief Financial Officer. Andy, thank you very much for joining us here. It's a privilege to have you.
Andrew D. Dickinson
Gilead Sciences, Inc. - Executive VP & CFO
Thanks for having me. I'm happy to be here. Appreciate the invitation.
Tyler Martin Van Buren
Cowen and Company, LLC, Research Division - Analyst
Right. Before we get started, I want to mention to the audience that you can submit questions via the web portal or e-mail me at [email protected] and I'll do my best to get those answered.
Questions & Answers
Tyler Martin Van Buren
Cowen and Company, LLC, Research Division - Analyst
So we
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot